JP6867210B2 - Patch - Google Patents
Patch Download PDFInfo
- Publication number
- JP6867210B2 JP6867210B2 JP2017068195A JP2017068195A JP6867210B2 JP 6867210 B2 JP6867210 B2 JP 6867210B2 JP 2017068195 A JP2017068195 A JP 2017068195A JP 2017068195 A JP2017068195 A JP 2017068195A JP 6867210 B2 JP6867210 B2 JP 6867210B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- sensitive adhesive
- pressure
- adhesive layer
- styrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 50
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 35
- 239000010410 layer Substances 0.000 claims description 31
- 230000000202 analgesic effect Effects 0.000 claims description 29
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 28
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 28
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 28
- 229920005989 resin Polymers 0.000 claims description 27
- 239000011347 resin Substances 0.000 claims description 27
- 230000004936 stimulating effect Effects 0.000 claims description 21
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 claims description 20
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 claims description 19
- 229960000192 felbinac Drugs 0.000 claims description 18
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 16
- 150000003505 terpenes Chemical class 0.000 claims description 13
- 235000007586 terpenes Nutrition 0.000 claims description 13
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 12
- 230000003078 antioxidant effect Effects 0.000 claims description 12
- 230000035807 sensation Effects 0.000 claims description 12
- 229920006223 adhesive resin Polymers 0.000 claims description 11
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 claims description 11
- 229960002504 capsaicin Drugs 0.000 claims description 8
- 235000017663 capsaicin Nutrition 0.000 claims description 8
- 239000012790 adhesive layer Substances 0.000 claims description 6
- 239000004840 adhesive resin Substances 0.000 claims description 5
- 229940007061 capsicum extract Drugs 0.000 claims description 5
- 239000001943 capsicum frutescens fruit extract Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 description 14
- 238000010792 warming Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- -1 softener Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 239000004902 Softening Agent Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000012943 hotmelt Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 229920006267 polyester film Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920002633 Kraton (polymer) Polymers 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 230000001760 anti-analgesic effect Effects 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 229940116257 pepper extract Drugs 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- FACXGONDLDSNOE-UHFFFAOYSA-N buta-1,3-diene;styrene Chemical compound C=CC=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 FACXGONDLDSNOE-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 238000007757 hot melt coating Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、支持体の片面に、非ステロイド系消炎鎮痛薬の一種であるフェルビナクを含有する粘着剤層が設けられた消炎鎮痛貼付剤に関する。本発明の消炎鎮痛貼付剤は、フェルビナクを経皮的に皮膚透過性良く局所組織内に投与することができ、しかも、貼付面積が少ない場合でも、患者に不快感を与えることなく適度の温感刺激性(効き目感)を持続することができる。 The present invention relates to an anti-inflammatory analgesic patch in which a pressure-sensitive adhesive layer containing felbinac, which is a kind of non-steroidal anti-inflammatory drug, is provided on one side of a support. The anti-inflammatory analgesic patch of the present invention can administer felbinac percutaneously into local tissues with good skin permeability, and even when the patch area is small, it does not cause discomfort to the patient and gives an appropriate warmth. The irritation (feeling of effectiveness) can be maintained.
フェルビナクは、フェニル酢酸誘導体の一種で、4−ビフェニル酢酸構造を有する非ステロイド系消炎鎮痛薬である。フェルビナクは、消炎鎮痛効果を示す薬物であり、皮膚透過性を有するため、例えば、貼付剤、パップ剤、プラスター剤、ゲル剤、ローションなどの経皮吸収型製剤として用いられている。 Felbinac is a kind of phenylacetic acid derivative and is a non-steroidal anti-inflammatory drug having a 4-biphenylacetic acid structure. Felbinac is a drug exhibiting an anti-inflammatory and analgesic effect, and because it has skin permeability, it is used as a transdermal preparation such as a patch, a poultice, a plaster, a gel, and a lotion.
非ステロイド系消炎鎮痛薬などの薬物は、消炎作用や鎮痛作用などの薬効は有するものの、効き目を感じるような刺激感はない。そこで、多くの経皮吸収型の非ステロイド系消炎鎮痛貼付剤では、L−メントール、DL−メントール、DL−カンフル、ハッカ油、カプサイシン、トウガラシエキス、ノニル酸ワニリルアミドなどの刺激効果を有する成分を添加して、冷感刺激効果または温感刺激効果を付与させることがよく行われている。 Drugs such as non-steroidal anti-inflammatory drugs have medicinal effects such as anti-inflammatory and analgesic effects, but they do not have a stimulating sensation to feel the effects. Therefore, in many transdermal non-steroidal anti-inflammatory analgesic patches, ingredients with stimulating effects such as L-menthol, DL-menthol, DL-camphor, peppermint oil, capsaicin, capsicum extract, and nonylate vanillylamide are added. Therefore, it is common practice to impart a cooling sensation stimulating effect or a warm sensation stimulating effect.
特に、カプサイシン、トウガラシエキス、ノニル酸ワニリルアミドなどの温感刺激効果を発現させる温感刺激成分は、ほぼ無臭であり、においの少ない経皮吸収剤によく用いられている。 In particular, warm sensation stimulating components such as capsaicin, capsicum extract, and nonyl acid vanillyl amide that exert a warm sensation stimulating effect are almost odorless and are often used as transdermal absorbents having little odor.
例えば、フェルビナクを含有する経皮吸収製剤に温感成分としてノニル酸ワニリルアミドを配合した経皮吸収型製剤も知られている。特開2008−179564(特許文献1)にはフェルビナクとテルペン系粘着付与樹脂とノニル酸ワニリルアミドを含む貼付剤が開示されている。
ここで、特許文献1の実施例には、支持体の片面に、フェルビナク、粘着剤基剤としてのスチレン−イソプレン−スチレンブロック共重合体、テルペン系粘着付与樹脂、温感刺激成分としてのノニル酸ワニリルアミド等を含有する粘着剤層が設けられた、70cm2(7cm×10cm)の貼付面積の貼付剤が、良好な刺激感を与えた(実施例1〜3)のに対して、テルペン系粘着付与樹脂の代わりにロジン系粘着付与樹脂を用いた同様の貼付剤では、刺激感の評価において良くない結果が得られたことが示されている(比較例2)。
For example, a transdermal preparation in which a transdermal preparation containing felbinac and a nonyl acid vanillylamide as a warming component is blended is also known. Japanese Patent Application Laid-Open No. 2008-179564 (Patent Document 1) discloses a patch containing felbinac, a terpene-based tackifier resin, and nonyl acid vanillylamide.
Here, in the examples of Patent Document 1, fervinac, a styrene-isoprene-styrene block copolymer as a pressure-sensitive adhesive base, a terpene-based pressure-sensitive adhesive resin, and nonyl acid as a warming stimulating component are used on one side of a support. A terpene-based adhesive was provided with a 70 cm 2 (7 cm × 10 cm) adhesive layer provided with an adhesive layer containing vanillylamide and the like, whereas the adhesive gave a good stimulating feeling (Examples 1 to 3). It has been shown that a similar patch using a rosin-based tackifier resin instead of the imparting resin gave poor results in the evaluation of irritation (Comparative Example 2).
特許文献1に記載されているような70cm2(7cm×10cm)前後の貼付面積の貼付剤が、従来用いられてきた一般的な大きさの貼付剤であるが、これらの比較的大きな貼付面積の貼付剤は皮膚に貼付するときにシワが入りやすく、必ずしも使い勝手が良いものではなかった。そのため、皮膚に貼り易い、貼付面積の小さな小型の貼付剤が望まれている。 A patch having a sticking area of about 70 cm 2 (7 cm × 10 cm) as described in Patent Document 1 is a patch of a general size that has been conventionally used, but these relatively large sticking areas The patch was not always easy to use because it was easy to wrinkle when it was applied to the skin. Therefore, a small patch having a small sticking area that is easy to stick to the skin is desired.
しかし、貼付面積を小さくすると、当然効き目感も少なくなり、それにより、効き目感の持続も短くなってしまう。一方、温感刺激成分の量を多くすれば、効き目感の持続は長くなるが、温感刺激成分が多すぎれば、貼付直後の温感刺激が強すぎ患者によっては我慢できずに貼付剤を剥がさなければならない場合があるという問題があった。 However, if the sticking area is reduced, the feeling of effectiveness is naturally reduced, and as a result, the duration of the feeling of effectiveness is also shortened. On the other hand, if the amount of the warmth stimulating component is increased, the effect will last longer, but if the amount of the warming stimulating component is too large, the warming stimulus immediately after application is too strong and some patients cannot tolerate the patch. There was a problem that it might have to be peeled off.
そのため、フェルビナク、粘着剤基剤としてのスチレン−イソプレン−スチレンブロック共重合体、テルペン系粘着付与樹脂等を含有する粘着剤層において、通常より多い0.004質量%以上の温感刺激成分を用いて、小型の貼付剤を作製したところ、過度の温感刺激は与えなかったものの、温感刺激による効き目感の持続は、2時間程度であり、決して長いものではなかった。 Therefore, in the pressure-sensitive adhesive layer containing fervinac, styrene-isoprene-styrene block copolymer as a pressure-sensitive adhesive base, terpene-based pressure-sensitive adhesive resin, etc., 0.004% by mass or more of a warming stimulating component, which is larger than usual, is used. When a small patch was prepared, an excessive warming stimulus was not given, but the effect of the warming stimulus lasted for about 2 hours, which was not long.
従って、本発明の課題は、フェルビナクを含有する粘着剤層が設けられた小型の消炎鎮痛貼付剤において、過度の温感刺激を与えることなく、かつ、適度の温感刺激による効き目感が長時間持続し得る貼付剤を提供することにある。 Therefore, the subject of the present invention is that in a small anti-inflammatory analgesic patch provided with an adhesive layer containing felbinac, the effect of an appropriate warming stimulus is long without giving an excessive warming stimulus. The purpose is to provide a sustainable patch.
本発明者らは、前記課題を解決するために鋭意研究を行った結果、フェルビナク、粘着剤基剤としてのスチレン−イソプレン−スチレンブロック共重合体、通常より多い0.01質量%以上の温感刺激成分等を含有する粘着剤層において、ロジン系粘着付与樹脂を用いて小型の貼付剤を作製したところ、過度の温感刺激を与えることなく、かつ、テルペン系粘着付与樹脂を用いた場合とは対照的に、適度の温感刺激による効き目感が長時間持続し得る(6〜8時間程度)ことを見出し、本発明を完成させた。 As a result of diligent research to solve the above problems, the present inventors have conducted ferbinac, a styrene-isoprene-styrene block copolymer as an adhesive base, and a warmth of 0.01% by mass or more, which is higher than usual. When a small patch was prepared using a rosin-based tackifier resin in the pressure-sensitive adhesive layer containing a stimulating component, the case where a terpene-based tackifier resin was used without giving an excessive warming stimulus. In contrast, they have found that the effect of an appropriate warming stimulus can be sustained for a long time (about 6 to 8 hours), and completed the present invention.
即ち、本発明は、
[1]支持体の片面に、フェルビナクを含有する粘着剤層が設けられた消炎鎮痛貼付剤において、該粘着剤層が、
(a)スチレン−イソプレン−スチレンブロック共重合体、
(b)ロジン系粘着付与樹脂、
(c)軟化剤、
(d)酸化防止剤、
(e)フェルビナク、並びに
(f)前記粘着剤層の総質量に基づいて0.01質量%乃至0.05質量%の範囲の、ノニル酸ワニリルアミド及びカプサイシン及びトウガラシエキスからなる群より選ばれる少なくとも一種の温感刺激成分
を含有する消炎鎮痛貼付剤、
[2]前記温感刺激成分を、前記粘着剤層の総質量に基づいて0.01質量%乃至0.03質量%の範囲で含有する前記[1]記載の消炎鎮痛貼付剤、
[3]貼付面積が5cm2乃至50cm2の範囲である前記[1]又は前記[2]記載の消炎鎮痛貼付剤、
[4]前記ロジン系粘着付与樹脂が、水添ロジン系粘着付与樹脂である前記[1]乃至前記[3]の何れか1つに記載の消炎鎮痛貼付剤
に関する。
That is, the present invention
[1] In an anti-inflammatory analgesic patch provided with a pressure-sensitive adhesive layer containing felbinac on one side of a support, the pressure-sensitive adhesive layer is formed.
(A) Styrene-isoprene-styrene block copolymer,
(B) Rosin-based adhesive resin,
(C) Softener,
(D) Antioxidant,
At least one selected from the group consisting of (e) felbinac and (f) nonylate vanillylamide and capsaicin and pepper extract in the range of 0.01% by mass to 0.05% by mass based on the total mass of the pressure-sensitive adhesive layer. Anti-inflammatory analgesic patch containing the warmth stimulating ingredient of
[2] The anti-inflammatory analgesic patch according to the above [1], which contains the warmth stimulating component in the range of 0.01% by mass to 0.03% by mass based on the total mass of the pressure-sensitive adhesive layer.
[3] The anti-inflammatory analgesic patch according to the above [1] or the above [2], which has a sticking area in the range of 5 cm 2 to 50 cm 2.
[4] The anti-inflammatory analgesic patch according to any one of the above [1] to the above [3], wherein the rosin-based tackifier resin is a hydrogenated rosin-based tackifier resin.
支持体の片面に、非ステロイド系消炎鎮痛薬であるフェルビナクを含有する粘着剤層を設けた本発明の消炎鎮痛貼付剤は、粘着剤層がスチレン−イソプレン−スチレンブロック共重合体、ロジン系粘着付与樹脂、軟化剤、酸化防止剤、フェルビナク、粘着剤層の総質量に基づいて0.01質量%乃至0.05質量%の範囲の、ノニル酸ワニリルアミド及びカプサイシン及びトウガラシエキスからなる群より選ばれる少なくとも一種の温感刺激成分を含むことによって、過度に温感刺激を起こすことなく、効き目感が持続できる。 In the anti-inflammatory analgesic patch of the present invention in which an adhesive layer containing felbinac, which is a non-steroidal anti-inflammatory analgesic, is provided on one side of a support, the adhesive layer is a styrene-isoprene-styrene block copolymer, rosin-based adhesive. Selected from the group consisting of vanillylamide nonylate and capsaicin and capsicum extract in the range of 0.01% by mass to 0.05% by mass based on the total mass of the imparting resin, softener, antioxidant, felbinac, and pressure-sensitive adhesive layer. By containing at least one kind of warm sensation stimulating component, the effect can be maintained without causing excessive warm sensation stimulus.
本発明の消炎鎮痛貼付剤は、支持体の片面に、フェルビナクを含有する粘着剤層が設けられた消炎鎮痛貼付剤において、該粘着剤層が、
(a)スチレン−イソプレン−スチレンブロック共重合体、
(b)ロジン系粘着付与樹脂、
(c)軟化剤、
(d)酸化防止剤、
(e)フェルビナク、並びに
(f)前記粘着剤層の総質量に基づいて0.01質量%乃至0.05質量%の範囲の、ノニル酸ワニリルアミド及びカプサイシン及びトウガラシエキスからなる群より選ばれる少なくとも一種の温感刺激成分を含有することを特徴とする。
The anti-inflammatory analgesic patch of the present invention is an anti-inflammatory analgesic patch in which a pressure-sensitive adhesive layer containing felbinac is provided on one side of a support.
(A) Styrene-isoprene-styrene block copolymer,
(B) Rosin-based adhesive resin,
(C) Softener,
(D) Antioxidant,
At least one selected from the group consisting of (e) felbinac and (f) nonylate vanillylamide and capsaicin and pepper extract in the range of 0.01% by mass to 0.05% by mass based on the total mass of the pressure-sensitive adhesive layer. It is characterized by containing a warming stimulating component of.
本発明に用いる薬効成分としてのフェルビナクとしては市販のものを用いることができる。
フェルビナクの含有量は、特に制限されるものではないが、粘着剤層の総質量に基づいて、好ましくは0.3〜10質量%、より好ましくは0.5〜5質量%である。
As the felbinac as a medicinal ingredient used in the present invention, a commercially available product can be used.
The content of felbinac is not particularly limited, but is preferably 0.3 to 10% by mass, more preferably 0.5 to 5% by mass, based on the total mass of the pressure-sensitive adhesive layer.
本発明に用いるスチレン−イソプレン−スチレンブロック共重合体は、粘着剤層に粘着性を付与するとともに、各成分を粘着剤層中に保持し、他の成分を溶解または分散させる役割を担うものである。スチレン−イソプレン−スチレンブロック共重合体の含有量は、粘着性、他の成分の保持性、フェルビナクの分散性などの観点から、粘着剤層の総質量に基づいて、好ましくは10〜40質量%、より好ましくは20〜35質量%である。 The styrene-isoprene-styrene block copolymer used in the present invention has a role of imparting adhesiveness to the pressure-sensitive adhesive layer, retaining each component in the pressure-sensitive adhesive layer, and dissolving or dispersing other components. is there. The content of the styrene-isoprene-styrene block copolymer is preferably 10 to 40% by mass based on the total mass of the pressure-sensitive adhesive layer from the viewpoints of tackiness, retention of other components, dispersibility of fervinac, and the like. , More preferably 20 to 35% by mass.
スチレン−イソプレン−スチレンブロック共重合体の含有量が少なすぎると、粘着剤層の凝集性や保型性が低下する傾向にある。他方、スチレン−イソプレン−スチレンブロック共重合体の含有量が多すぎると、粘着力の低下、粘着剤層中の各成分の不均一化、あるいは各成分の混合作業や粘着剤組成物の塗工作業などにおける作業性の低下を招きやすくなる。 If the content of the styrene-isoprene-styrene block copolymer is too small, the cohesiveness and shape retention of the pressure-sensitive adhesive layer tend to decrease. On the other hand, if the content of the styrene-isoprene-styrene block copolymer is too large, the adhesive strength is lowered, each component in the pressure-sensitive adhesive layer is made non-uniform, or each component is mixed and the pressure-sensitive adhesive composition is applied. It tends to cause a decrease in workability in work.
本発明に用いるスチレン−イソプレン−スチレンブロック共重合体は、特に限定されず市販されているものを用いてもよい。市販されている、スチレン−イソプレン−スチレンブロック共重合体としては、日本ゼオン(株)製の商品名クインタック3520,3530,3421、JSR(株)製の商品名SIS5000、5002、5229、クレイトンポリマージャパン(株)製の商品名クレイトンD(SIS)シリーズなどがある。また、これらを1種又は2種以上の組み合わせで用いることもできる。 The styrene-isoprene-styrene block copolymer used in the present invention is not particularly limited, and commercially available ones may be used. Commercially available styrene-isoprene-styrene block copolymers include ZEON CORPORATION's trade name Quintac 3520, 3530, 3421, JSR Corporation's trade name SIS5000, 5002, 5229, and Kraton Polymer. There is a brand name Kraton D (SIS) series manufactured by Japan Co., Ltd. Further, these may be used alone or in a combination of two or more kinds.
本発明に用いるスチレン−イソプレン−スチレンブロック共重合体のスチレン含有量は特に限定されないが、10%〜30%が好ましく、13%〜26%がより好ましい。 The styrene content of the styrene-isoprene-styrene block copolymer used in the present invention is not particularly limited, but is preferably 10% to 30%, more preferably 13% to 26%.
ロジン系粘着付与樹脂はロジンまたはロジン誘導体であり、ロジンエステル、水添ロジンエステル、水添ロジングリセリンエステル等を用いることができ、水添ロジンエステルが好ましく、水添ロジングリセリンエステルがより好ましい。
本発明に用いるロジン系粘着付与樹脂の軟化点は、特に限定されないが、80℃〜110℃が好ましく、90℃〜110℃がより好ましく、95℃〜105℃がさらに好ましい。
The rosin-based tackifier resin is a rosin or a rosin derivative, and rosin ester, hydrogenated rosin ester, hydrogenated rosin lyserine ester and the like can be used, and hydrogenated rosin ester is preferable, and hydrogenated rosin lyserine ester is more preferable.
The softening point of the rosin-based tackifier resin used in the present invention is not particularly limited, but is preferably 80 ° C. to 110 ° C., more preferably 90 ° C. to 110 ° C., and even more preferably 95 ° C. to 105 ° C.
本発明に用いるロジン系粘着付与樹脂は、市販されているものを用いてもよく、具体的な市販されているロジン系粘着付与樹脂としては、荒川化学工業(株)製の商品名エステルガム、ペンセル、スーパーエステル、パインクリスタルなどが挙げられる。 As the rosin-based tackifier resin used in the present invention, a commercially available one may be used, and as a specific commercially available rosin-based tackifier resin, a trade name ester gum manufactured by Arakawa Chemical Industry Co., Ltd., Examples include pencils, superesters and pine crystals.
本発明に使用し得るロジン系粘着付与樹脂は、上記で列挙したものを単独で用いることもできるが、2種以上を組み合わせで用いることもできる。
ロジン系粘着付与樹脂の使用量は、粘着剤層の総質量に基づいて、好ましくは20〜40質量%、より好ましくは25〜35質量%である。
As the rosin-based tackifier resin that can be used in the present invention, those listed above can be used alone, or two or more kinds can be used in combination.
The amount of the rosin-based tackifier resin used is preferably 20 to 40% by mass, more preferably 25 to 35% by mass, based on the total mass of the pressure-sensitive adhesive layer.
本発明に用いる軟化剤は、特に限定されないが、植物油、液状ポリイソブレン、液状ポリブテン、流動パラフィン等を用いることができ、流動パラフィンがより好ましい。
軟化剤の使用量は、粘着剤層の総質量に基づいて、好ましくは30〜50質量%、より好ましくは35〜45質量%である。
The softening agent used in the present invention is not particularly limited, but vegetable oil, liquid polyisobrene, liquid polybutene, liquid paraffin and the like can be used, and liquid paraffin is more preferable.
The amount of the softener used is preferably 30 to 50% by mass, more preferably 35 to 45% by mass, based on the total mass of the pressure-sensitive adhesive layer.
本発明に用いる酸化防止剤は公知のものを用いることができ、特に限定されないが、ジブチルヒドロキシトルエンが好ましい。
酸化防止剤の使用量は、粘着剤層の総質量に基づいて、好ましくは0.1〜30質量%、より好ましくは0.1〜1質量%である。
As the antioxidant used in the present invention, known ones can be used, and the antioxidant is not particularly limited, but dibutylhydroxytoluene is preferable.
The amount of the antioxidant used is preferably 0.1 to 30% by mass, more preferably 0.1 to 1% by mass, based on the total mass of the pressure-sensitive adhesive layer.
本発明に用いるノニル酸ワニリルアミド及びカプサイシン及びトウガラシエキスからなる群より選ばれる少なくとも一種の温感刺激成分は市販のものを用いることができる。ノニル酸ワニリルアミドがより好ましい。
温感刺激成分の使用量は、粘着剤層の総質量に基づいて、0.01〜0.05質量%の範囲であるが、この使用量は、通常の市販の70cm2(7cm×10cm)前後の貼付面積の貼付剤における使用量よりも多いものとなる。温感刺激成分の好ましい使用量の範囲としては、0.015〜0.04質量%、0.01〜0.03質量%、0.015〜0.03質量%等が挙げられる。
As at least one warm sensation stimulating component selected from the group consisting of nonylic acid vanillylamide, capsaicin, and capsicum extract used in the present invention, commercially available ones can be used. Nonyl acid vanillyl amide is more preferred.
The amount of the warmth stimulating component used is in the range of 0.01 to 0.05% by mass based on the total mass of the pressure-sensitive adhesive layer, but this amount is usually 70 cm 2 (7 cm × 10 cm) on the market. It will be larger than the amount used in the patch in the front and back sticking areas. The range of the preferable amount of the warm sensation stimulating component is 0.015 to 0.04% by mass, 0.01 to 0.03% by mass, 0.015 to 0.03% by mass, and the like.
本発明の消炎鎮痛貼付剤の粘着剤層は、一般的な消炎鎮痛貼付剤の製造方法であるカレンダー法やホットメルト法などにより作製することができる。 The pressure-sensitive adhesive layer of the anti-inflammatory analgesic patch of the present invention can be produced by a calendar method, a hot melt method, or the like, which is a general method for producing an anti-inflammatory analgesic patch.
カレンダー法では、はじめに、加圧ニーダーで、スチレン−イソプレン−スチレンブロック共重合体、粘着付与樹脂、酸化防止剤並びにフェルビナクを、100〜150℃で10〜30分間混練り後、可塑剤を数回に分けて添加して混練りを継続し、最後にノニル酸ワニリルアミドを添加して、さらに5〜20分間混練りして、各成分が均一となった粘着剤組成物を得る。上記の混練時の温度及び時間は、例を挙げて説明したものであり、これらの範囲に限定されるものではない。 In the calendar method, first, a styrene-isoprene-styrene block copolymer, a tackifier resin, an antioxidant and fervinac are kneaded with a pressure kneader at 100 to 150 ° C. for 10 to 30 minutes, and then the plasticizer is applied several times. The mixture is divided into two portions to continue kneading, and finally nonylate vanillylamide is added and kneaded for another 5 to 20 minutes to obtain a pressure-sensitive adhesive composition in which each component is uniform. The temperature and time at the time of kneading are described by way of example, and are not limited to these ranges.
前記方法にて得られた粘着剤組成物(膏体)を、カレンダー塗工機にて、100〜200℃に温度制御した2本のロール間を通して剥離ライナー上に100〜250μmの厚さに展延した後、これに、支持体をラミネートし、消炎鎮痛貼付剤を作製する。 The pressure-sensitive adhesive composition (plaster) obtained by the above method is spread on a release liner to a thickness of 100 to 250 μm through two rolls whose temperature is controlled to 100 to 200 ° C. using a calendar coating machine. After spreading, a support is laminated on this to prepare an anti-inflammatory analgesic patch.
ホットメルト法とは、加熱制御可能な高速回転ミキサーで、最初にスチレン−イソプレン−スチレンブロック共重合体、粘着付与樹脂、酸化防止剤、及び軟化剤を、窒素雰囲気下、100〜190℃の膏体温度で20〜100分間加熱高速撹拌して溶解物とする。その後、有効成分であるフェルビナクと温感刺激成分であるノニル酸ワニリルアミド、またはカプサイシンを前記溶融物中に添加し、さらに120〜190℃の膏体温度で5〜30分間加熱高速撹拌して各成分が均一となった粘着剤組成物を得る。上記の撹拌時の温度及び時間は、例を挙げて説明したものであり、これらの範囲に限定されるものではない。 The hot melt method is a high-speed rotary mixer with heat control, in which styrene-isoprene-styrene block copolymer, tackifier resin, antioxidant, and softener are first applied in a nitrogen atmosphere at 100 to 190 ° C. Heat at body temperature for 20 to 100 minutes and stir at high speed to obtain a lysate. Then, felbinac, which is an active ingredient, and vanillylamide nonylate, which is a warming stimulant ingredient, or capsaicin are added to the melt, and each component is further heated at a plaster temperature of 120 to 190 ° C. for 5 to 30 minutes and stirred at high speed. To obtain a pressure-sensitive adhesive composition in which is uniform. The above-mentioned temperature and time during stirring have been described by way of example, and are not limited to these ranges.
前記方法にて得られた粘着剤組成物(膏体)を、ホットメルト塗工機にて、100〜200℃に温度制御したダイヘッド部分から押し出して剥離ライナー上に100〜250μmの厚さに展延した後、これに、支持体をラミネートし、消炎鎮痛貼付剤を作製する。 The pressure-sensitive adhesive composition (plaster) obtained by the above method is extruded from a die head portion whose temperature is controlled to 100 to 200 ° C. by a hot melt coating machine and spread on a release liner to a thickness of 100 to 250 μm. After spreading, a support is laminated on this to prepare an anti-inflammatory analgesic patch.
これらの方法にて、本発明における消炎鎮痛貼付剤を得ることができるが、製造方法としてはこれらに限定されるものではない。 The anti-inflammatory analgesic patch of the present invention can be obtained by these methods, but the production method is not limited to these.
支持体としては、フィルム、不織布、和紙、綿布、編布、不織布とフィルムのラミネート複合体等の柔軟性を有する支持体が挙げられる。これらの支持体は、皮膚に密着することができ、かつ、皮膚の動きに追随することができる程度の柔軟な材質が好ましい。これらの支持体の材質としては、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリエチレンナフタレート、ポリスチレン、ナイロン、コットン、アセテートレーヨン、レーヨン、レーヨン/ポリエチレンテレフタレート複合体、ポリアクリロニトリル、ポリビニルアルコール、アクリル系ポリウレタン、エステル系ポリウレタン、エーテル系ポリウレタン、スチレン−イソプレン−スチレン共重合体、スチレン−ブタジエン−スチレン共重合体、スチレン−エチレン−プロピレン−スチレン共重合体、スチレン−ブタジエンゴム、エチレン−酢酸ビニル共重合体、セロハン等を必須成分とするものが挙げられる。支持体としては、薬物が吸着されず、かつ、支持体側から薬物が放出されないものが好ましい。 Examples of the support include a flexible support such as a film, a non-woven fabric, Japanese paper, a cotton cloth, a knitted cloth, and a laminated composite of a non-woven fabric and a film. These supports are preferably made of a flexible material that can adhere to the skin and can follow the movement of the skin. Examples of the material of these supports include polyethylene, polypropylene, polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polystyrene, nylon, cotton, acetate rayon, rayon, rayon / polyethylene terephthalate composite, polyacrylonitrile, polyvinyl alcohol, and the like. Acrylic polyurethane, ester polyurethane, ether polyurethane, styrene-isoprene-styrene copolymer, styrene-butadiene-styrene copolymer, styrene-ethylene-propylene-styrene copolymer, styrene-butadiene rubber, ethylene-vinyl acetate Examples thereof include those containing a copolymer, cellophane, etc. as essential components. As the support, it is preferable that the drug is not adsorbed and the drug is not released from the support side.
前記剥離ライナーとしては、シリコーン処理したポリエステルフィルム、シリコーン処理したポリエチレンラミネート上質紙、シリコーン処理したグラシン紙などが挙げられる。剥離ライナーとしては、薬物が吸収・吸着しにくい材質であることが好ましい。 Examples of the release liner include a silicone-treated polyester film, a silicone-treated polyethylene-laminated wood-free paper, and a silicone-treated glassine paper. The release liner is preferably made of a material that does not easily absorb or adsorb the drug.
本発明の貼付剤の貼付面積は、通常の市販の70cm2(7cm×10cm)前後の貼付面積の貼付剤よりも小さいものであり、貼付しやすさを考慮すると5cm2〜50cm2が好ましく、5cm2〜40cm2がより好ましい。 The sticking area of the patch of the present invention is smaller than that of a normal commercially available patch with a sticking area of about 70 cm 2 (7 cm × 10 cm), and 5 cm 2 to 50 cm 2 is preferable in consideration of ease of sticking. 5cm 2 ~40cm 2 is more preferable.
実施例1
スチレン−イソプレン−スチレンブロック共重合体としてJSR(株)製の商品名SIS5229(スチレン含有量15%)を25.0質量%、ロジン系粘着付与樹脂として荒川化学工業(株)製の商品名パインクリスタルKE−311(水添ロジングリセリンエステル、軟化点90〜100℃)を31.5質量%、軟化剤としてカネダ株式会社の商品名ハイコールM352(流動パラフィン)を38.0質量%、酸化防止剤として薬添BHT(ジブチルヒドロキシトルエン)を0.5質量%、フェルナビクを5.0質量%及びノニル酸ワニルアミドを0.02質量%配合し、該配合処方においてホットメルト法で加熱撹拌を行い、均一な粘着剤組成物を調製した。次いで、該粘着剤組成物をシリコーン処理したポリエステルフィルム(厚さ75μm)上に、100μmの厚さに展延して、粘着剤層を形成した。この粘着剤層の上に支持体としてポリエステル系編布をラミネートし、36cm2(6cm×6cm)の貼付面積となるよう裁断し、消炎鎮痛貼付剤を作製した。
Example 1
25.0% by mass of SIS5229 (styrene content 15%) manufactured by JSR Co., Ltd. as a styrene-isoprene-styrene block copolymer, and pine manufactured by Arakawa Chemical Industry Co., Ltd. as a rosin-based tackifier resin. Crystal KE-311 (hydrogenated rosin styrene ester, softening point 90-100 ° C) is 31.5% by mass, and as a softening agent, Kaneda Co., Ltd.'s trade name Hicol M352 (liquid paraffin) is 38.0% by mass, an antioxidant. BHT (dibutylhydroxytoluene) was added in an amount of 0.5% by mass, fernabic was added in an amount of 5.0% by mass, and wanylamide nonylate was added in an amount of 0.02% by mass. A suitable pressure-sensitive adhesive composition was prepared. Next, the pressure-sensitive adhesive composition was spread on a silicone-treated polyester film (thickness 75 μm) to a thickness of 100 μm to form a pressure-sensitive adhesive layer. A polyester-based knitted cloth was laminated on the pressure-sensitive adhesive layer as a support and cut so as to have a sticking area of 36 cm 2 (6 cm × 6 cm) to prepare an anti-inflammatory and pain-relieving patch.
比較例1
スチレン−イソプレン−スチレンブロック共重合体としてJSR(株)製の商品名SIS5229(スチレン含有量15%)を25.0質量%、テルペン系粘着付与樹脂として荒川化学工業(株)製の商品名YSレジンPX1150N(テルペン系樹脂、軟化点115℃)を31.5質量%、軟化剤としてカネダ株式会社の商品名ハイコールM352(流動パラフィン)を38.0質量%、酸化防止剤として薬添BHT(ジブチルヒドロキシトルエン)を0.5質量%、フェルナビクを5.0質量%及びノニル酸ワニルアミドを0.004質量%配合し、該配合処方においてホットメルト法で加熱撹拌を行い、均一な粘着
剤組成物を調製した。次いで、該粘着剤組成物をシリコーン処理したポリエステルフィルム(厚さ75μm)上に、100μmの厚さに展延して、粘着剤層を形成した。この粘着剤層の上に支持体としてポリエステル系編布をラミネートし、36cm2(6cm×6cm)の貼付面積となるよう裁断し、消炎鎮痛貼付剤を作製した。ロジン系粘着付与樹脂の代わりにテルペン系粘着付与樹脂のYSレジンPX1150Nを用い、ノニル酸ワニルアミドの配合量を0.004質量%とした以外は実施例1と同じである。
Comparative example 1
25.0% by mass of SIS5229 (styrene content 15%) manufactured by JSR Co., Ltd. as a styrene-isoprene-styrene block copolymer, and YS manufactured by Arakawa Chemical Industry Co., Ltd. as a terpene adhesive resin. Resin PX1150N (terpene resin, softening point 115 ° C) is 31.5% by mass, Kaneda Co., Ltd. brand name Hicol M352 (liquid paraffin) is 38.0% by mass as a softening agent, and Yakuzo BHT (dibutyl) is used as an antioxidant. (Hydroxytoluene) was blended in 0.5% by mass, fernavik in 5.0% by mass, and nonylate vanilamide in 0.004% by mass, and the compounding formulation was heated and stirred by a hot melt method to obtain a uniform pressure-sensitive adhesive composition. Prepared. Next, the pressure-sensitive adhesive composition was spread on a silicone-treated polyester film (thickness 75 μm) to a thickness of 100 μm to form a pressure-sensitive adhesive layer. A polyester-based knitted cloth was laminated on the pressure-sensitive adhesive layer as a support and cut so as to have a sticking area of 36 cm 2 (6 cm × 6 cm) to prepare an anti-inflammatory and pain-relieving patch. This is the same as in Example 1 except that YS resin PX1150N, which is a terpene-based pressure-sensitive adhesive resin, is used instead of the rosin-based pressure-sensitive adhesive resin, and the blending amount of nonylate vanilamide is 0.004% by mass.
比較例2
スチレン−イソプレン−スチレンブロック共重合体としてJSR(株)製の商品名SIS5229(スチレン含有量15%)を25.0質量%、テルペン系粘着付与樹脂として荒川化学工業(株)製の商品名YSレジンPX1150N(テルペン系樹脂、軟化点115℃)を31.5質量%、軟化剤としてカネダ株式会社の商品名ハイコールM352(流動パラフィン)を38.0質量%、酸化防止剤として薬添BHT(ジブチルヒドロキシトルエン)を0.5質量%、フェルナビクを5.0質量%及びノニル酸ワニルアミドを0.02質量%配合し、該配合処方においてホットメルト法で加熱撹拌を行い、均一な粘着剤組成物を調製した。次いで、該粘着剤組成物をシリコーン処理したポリエステルフィルム(厚さ75μm)上に、100μmの厚さに展延して、粘着剤層を形成した。この粘着剤層の上に支持体としてポリエステル系編布をラミネートし、36cm2(6cm×6cm)の貼付面積となるよう裁断し、消炎鎮痛貼付剤を作製した。ロジン系粘着付与樹脂の代わりにテルペン系粘着付与樹脂のYSレジンPX1150Nを用いた以外は実施例1と同じである。この比較例2の消炎鎮痛剤の温感刺激による効き目感を官能評価にて評価しようとしたが、評価者11名全員が貼付後10〜20分で痛みを感じ貼付剤を剥がさねばならなかったので評価は中止した。
Comparative Example 2
25.0% by mass of SIS5229 (styrene content 15%) manufactured by JSR Co., Ltd. as a styrene-isoprene-styrene block copolymer, and YS manufactured by Arakawa Chemical Industry Co., Ltd. as a terpene adhesive resin. Resin PX1150N (terpene resin, softening point 115 ° C) is 31.5% by mass, Kaneda Co., Ltd. brand name Hicol M352 (liquid paraffin) is 38.0% by mass as a softening agent, and Yakuzo BHT (dibutyl) is used as an antioxidant. (Hydroxytoluene) was blended in 0.5% by mass, fernavik in 5.0% by mass, and nonylate vanilamide in 0.02% by mass, and the compounding formulation was heated and stirred by a hot melt method to obtain a uniform pressure-sensitive adhesive composition. Prepared. Next, the pressure-sensitive adhesive composition was spread on a silicone-treated polyester film (thickness 75 μm) to a thickness of 100 μm to form a pressure-sensitive adhesive layer. A polyester-based knitted cloth was laminated on the pressure-sensitive adhesive layer as a support and cut so as to have a sticking area of 36 cm 2 (6 cm × 6 cm) to prepare an anti-inflammatory and pain-relieving patch. This is the same as in Example 1 except that YS resin PX1150N, which is a terpene-based pressure-sensitive adhesive resin, is used instead of the rosin-based pressure-sensitive adhesive resin. An attempt was made to evaluate the efficacy of the anti-inflammatory analgesic of Comparative Example 2 by a warm sensation stimulus by sensory evaluation, but all 11 evaluators felt pain 10 to 20 minutes after application and had to remove the application. So the evaluation was stopped.
試験例1
上記で作製した実施例1及び比較例1の消炎鎮痛貼付剤の温感刺激による効き目感を官能評価にて評価した。
尚、温感刺激による効き目感の評価方法は下記の方法で行った。
評点0〜10における評価の指標及びスコアを以下のように設定し、各消炎鎮痛貼付剤の温感刺激による効き目感をスコア化した。
ここで、評点5が最も心地よく、評点10が強すぎ、評点0が効き目無しであることを意味する。
は11名で行いその平均値を平均スコアとした。
Test Example 1
The effect of the anti-inflammatory analgesic patch prepared above in Example 1 and Comparative Example 1 due to the warm sensation was evaluated by sensory evaluation.
The method for evaluating the effect of the warmth stimulus was as follows.
The evaluation indexes and scores on the scores 0 to 10 were set as follows, and the effect of each anti-inflammatory and pain-relieving patch by the warm sensation was scored.
Here, a score of 5 is the most comfortable, a score of 10 is too strong, and a score of 0 is ineffective.
実施1例及び比較例1で得た消炎鎮痛貼付剤を貼付した後、1時間、2時間、4時間、6時間及び8時間における温感刺激による効き目感の平均スコアを表2及び図1に示した。
表2及び図1から、ロジン系エステルを用いた実施例1の消炎鎮痛貼付剤はテルペン系樹脂を用いた比較例1の消炎鎮痛貼付剤と比較して、効き目感の持続が長く、良好であることが確認された。
尚、実施1例及び比較例1の消炎鎮痛貼付剤は、何れも過度の温感刺激を与えるものではなかった。
From Table 2 and FIG. 1, the anti-inflammatory analgesic patch of Example 1 using the rosin-based ester has a longer duration of efficacy and is better than the anti-inflammatory analgesic patch of Comparative Example 1 using the terpene resin. It was confirmed that there was.
Neither the anti-inflammatory analgesic patch of Example 1 and Comparative Example 1 gave an excessive warming stimulus.
Claims (4)
(a)スチレン−イソプレン−スチレンブロック共重合体、
(b)ロジン系粘着付与樹脂、
(c)軟化剤、
(d)酸化防止剤、
(e)フェルビナク、並びに
(f)前記粘着剤層の総質量に基づいて0.01質量%乃至0.05質量%の範囲の、ノニル酸ワニリルアミド及びカプサイシン及びトウガラシエキスからなる群より選ばれる少なくとも一種の温感刺激成分
を含有する消炎鎮痛貼付剤(但し、該粘着剤層はテルペン系樹脂を含まない)。 In an anti-inflammatory analgesic patch provided with a felbinac-containing pressure-sensitive adhesive layer on one side of a support, the pressure-sensitive adhesive layer is
(A) Styrene-isoprene-styrene block copolymer,
(B) Rosin-based adhesive resin,
(C) Softener,
(D) Antioxidant,
At least one selected from the group consisting of (e) felbinac and (f) nonylate vanillylamide and capsaicin and capsicum extract in the range of 0.01% by mass to 0.05% by mass based on the total mass of the pressure-sensitive adhesive layer. An anti-inflammatory analgesic patch containing the warmth stimulating component of (however, the adhesive layer does not contain a terpene resin) .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017068195A JP6867210B2 (en) | 2017-03-30 | 2017-03-30 | Patch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017068195A JP6867210B2 (en) | 2017-03-30 | 2017-03-30 | Patch |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018168125A JP2018168125A (en) | 2018-11-01 |
JP6867210B2 true JP6867210B2 (en) | 2021-04-28 |
Family
ID=64018407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017068195A Active JP6867210B2 (en) | 2017-03-30 | 2017-03-30 | Patch |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6867210B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019146614A1 (en) * | 2018-01-24 | 2019-08-01 | 久光製薬株式会社 | Patch |
WO2021201152A1 (en) * | 2020-03-31 | 2021-10-07 | ニチバン株式会社 | Adhesive patch |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3495733B2 (en) * | 1996-12-06 | 2004-02-09 | 久光製薬株式会社 | Patch containing felbinac |
JP4311728B2 (en) * | 2003-12-10 | 2009-08-12 | ニチバン株式会社 | Transdermal patch |
CN101184479B (en) * | 2005-06-01 | 2011-05-04 | 尼普洛外用药品株式会社 | Skin patch |
JP5365964B2 (en) * | 2010-12-28 | 2013-12-11 | ニチバン株式会社 | Transdermal absorption-type analgesic / anti-inflammatory patch |
JP5474154B1 (en) * | 2012-10-10 | 2014-04-16 | ニチバン株式会社 | Hot-melt adhesive composition and transdermal patch |
-
2017
- 2017-03-30 JP JP2017068195A patent/JP6867210B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018168125A (en) | 2018-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4399044B2 (en) | Absorption enhancer and transdermal absorption preparation comprising the absorption enhancer | |
JP4422430B2 (en) | External patch containing estrogen and / or progestogen | |
WO2001052823A2 (en) | Compositions to effect the release profile in the transdermal administration of drugs | |
WO2010095578A1 (en) | Adhesive composition and adhesive tape | |
JP5365964B2 (en) | Transdermal absorption-type analgesic / anti-inflammatory patch | |
JP4590418B2 (en) | Anti-inflammatory analgesic patch | |
JP6867210B2 (en) | Patch | |
JP6516917B2 (en) | Patch | |
WO1999036061A1 (en) | Plasticizer and patch containing the plasticizer | |
EP3744321B1 (en) | Patch | |
JP5767417B1 (en) | Patch | |
JP5192722B2 (en) | External patch | |
JP7142613B2 (en) | patch | |
JPH01297069A (en) | Tacky adhesive agent composition | |
JP2632838B2 (en) | External patch | |
JPH01297059A (en) | Warm heat sticking agent | |
JP2000256214A (en) | Antiphlogistic-sedative plaster | |
JP6963663B2 (en) | Manufacturing method of patch | |
JP2007031322A (en) | Plaster | |
JP6892567B1 (en) | Tape agent | |
WO2021131032A1 (en) | Adhesive patch | |
JP2006225319A (en) | Patch preparation | |
JP2022050912A (en) | Analgesic anti-inflammatory patch | |
JPH0714866B2 (en) | Transdermal patch | |
JPH09194349A (en) | Sheet for skin strap |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200323 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210217 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210407 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210408 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6867210 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |